Erasca, Inc. — Form D/A
Erasca, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2019-03-11. The offering totals $70.0M, of which $58.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-03-11
- Form: D/A
- Accession: 0001567619-19-006548
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $58.3M
- Remaining: $11.7M
- Investors: 41
- Date of first sale: 2018-10-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-330625
Issuer
- Name: Erasca, Inc.
- CIK: 0001761918
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 10835 Road to The Cure, Ste. 140, San Diego, CA, 92121
- Phone: (858) 465-6511
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Gary E Yeung, CFA | Executive Officer | San Diego, CA |
| Jonathan E Lim, M.D. | Director | LA JOLLA, CA |
| Jonathan E Lim, M.D. | Executive Officer | LA JOLLA, CA |
| Pratik S Multani, M.D. | Director | San Diego, CA |
| Valerie S Harding-Start | Director | San Diego, CA |
| Alexander W Casdin | Director | San Diego, CA |
| James A Bristol, Ph.D. | Director | San Diego, CA |
| Jonathan Lim, M.D. | Director | San Diego, CA |
| Jonathan Lim, M.D. | Executive Officer | San Diego, CA |
| Gary Yeung, CFA | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More